Effect of co-transplantation of mesenchymal stem cells and hematopoietic stem cells as compared to hematopoietic stem cell transplantation alone in renal transplantation to achieve donor hypo-responsiveness
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
We evaluated donor hypo-responsiveness in renal allograft recipients to donor adipose tissue-derived mesenchymal stem cell (h-AD-MSC) +hematopoietic stem cell transplantation (HSCT) vs. HSCT alone.
Patients were divided into 2 demographically equal groups (n = 100) A and B subjected to equal non-myeloablative conditioning of target-specific irradiation, anti-T + B cell antibodies and cyclophosphamide with HSCT. Group A was administered h-AD-MSC additionally. Transplantation was performed following favorable cross-matching. Cyclosporine, 3 mg/kg BW/day + prednisone, 20 mg/day were immunosuppressants for first 3 months, cyclosporine was replaced by azathioprine subsequently and prednisone lowered to 5–10 mg/day. Peripheral blood chimerism (PBC) was studied using fluorescent in situ hybridization technique at 3/18 months post transplant. Biopsy was performed for graft dysfunction and reported as per Banff criteria,’05.
Mean nucleated HSC counts (n × 108/kgBW) was 7.32 with mean CD34+ yield 0.09% in group A; and 6.98 and 0.40% in group B, respectively; CD45−/90+ was 13.49% in former. Over 18 months post transplant, former had mean serum creatinine (SCr), 1.59 mg%, 12% acute rejection (AR) episodes, 3% patient, 1% patient +graft loss; latter had mean SCr 1.49 mg%, 18% AR episodes, 1% patient, 6% graft and 8% patient +graft losses. PBC was higher (4%) in former than later (1.8%).
Combined h-AD-MSC +HSCT under non-myeloablative conditioning was safe, more effective than HSCT alone to achieve donor hypo-responsiveness with adequate stable graft function and reduced rejection episodes.
- Billingham RE, Brent L, Medawar PB (1953) ‘Actively acquired tolerance’ of foreign cells. Nature 172:603–606 CrossRef
- Fontes P, Rao AS, Demetris AJ et al (1994) Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart and pancreas islet transplantation. Lancet 172:603–606
- Owen RD (1945) Immunogenetic consequences of vascular anastomoses between bovine twins. Science 102:400–401 CrossRef
- Calne RY (2005) Prope tolerance—the future of organ transplantation from the laboratory to the clinic. Int Immunopharmaco 5(1):163–167 CrossRef
- Trivedi HL, Shah VR, Vanikar AV et al (2002) High dose allogeneic peripheral blood stem cell infusion—a strategy to induce allograft hypo-responsiveness in pediatric renal transplant recipients. Pediatr Transpl 6:63–68 CrossRef
- Trivedi HL, Vanikar AV, Modi PR et al (2005) Allogeneic hematopoietic stem cell transplantation, mixed chimerism and tolerance in living-related donor renal allograft recipients. Transpl Proc 37:737–742 CrossRef
- Solez K, Colvin RB, Racusen LR, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitrou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madrigua L, Salomon DR, Seron D, Sheaff M, Weening JJ (2007) Banff’05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (‘CAN’). Am J Transplant 7:518–526 CrossRef
- Sharabi Y, Sachs DH (1989) Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 169:493–502 CrossRef
- Kawai T, Cosimi AB, Spitzer TR et al (2008) HLA-Mismatched renal transplantation without immunosuppression. NEJM 358(4):353–361 CrossRef
- Trivedi H, Vanikar A, Modi P et al (2007) In pursuit of the ultimate: the initial Ahmadabad journey towards transplantation tolerance. Transplant Proc 39(3):773–778 CrossRef
- Schaffler A, Buchler C (2007) Concise review: adipose tissue derived stroma cells- basic and clinical Implications for novel cell- based therapies. Stem Cells 25:818–827 CrossRef
- Maitra B, Szekely E, Gjini K et al (2004) Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T -cell activation. Bone Marrow Transplant 33:597–604 CrossRef
- Beyth S, Borovsky Z, Mevorach D et al (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105(5):2214–2219 CrossRef
- Effect of co-transplantation of mesenchymal stem cells and hematopoietic stem cells as compared to hematopoietic stem cell transplantation alone in renal transplantation to achieve donor hypo-responsiveness
International Urology and Nephrology
Volume 43, Issue 1 , pp 225-232
- Cover Date
- Print ISSN
- Online ISSN
- Springer Netherlands
- Additional Links
- Adipose tissue-derived mesenchymal stem cell
- Hematopoietic stem cell transplantation
- Renal transplantation
- Donor hypo-responsiveness
- Industry Sectors